The Prevalence of Celiac Disease in Patients with Diabetes Mellitus—The Prevalence of Celiac Disease
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
Abstract
AIM: To determine the prevalence of celiac disease related autoantibodies in patients with type 1 and 2 diabetes mellitus (DM), and to compare these results with the general population. METHODS: In total, 137 consecutive patients with type 1 DM, 172 with type 2 DM and 113 age-sex matched control subjects were included into the study. Antigliadin-autoantibodies (AGA) IgG and IgA, and endomysial-antibodies(EMA) IgG and IgA antibodies were determined. Patients who were positive for one or more were offered a gastroduodenoscopic examination. RESULTS: AGA IgG positivity was detected in 38.7% (53/137) patients with type 1 DM in 26.2% (45/172) patients with type 2 DM and in 16.8% (19/113) control subjects (significant differences). AGA IgA positivity was detected in 24.8% (34/137) patients with type 1 DM, in 9.3% (16/172) patients with type 2 DM and in 3.5% (4/113) control subjects (significant differences). EMA IgG positivity was detected in 10.2% (14/137) patients with type 1 DM in 0.6% (1/176) patients with type 2 DM and 0.9% (1/113) control subjects (significant differences). EMA IgA positivity was detected in 11.7% (16/137) patients with type 1 DM in 0.6% (1/172) patients with type 2 DM and in none of control subjects. EMA IgA positivity was sig- nificantly higher in patients with type 1 DM as compared with patients with type 2 DM and controls. CONCLUSION: High prevalence of celiac disease at the diagnosis of type 1 DM is observed. Serological markers are useful for identifying celiac disease patients with type 1 DM.
- Farrell RJ, Kelly CP. Celiac sprue and refractory sprue.Fordtran and Sleisenger Gastrointestinal and liver disease. Vol. 2 pp. 2277-2306
- Dirks M. Preventive health care, 2004 update: screening persons with insulin-dependent diabetes mellitus with se- rology for celiac disease: systematic review & recom- mendations. CMAJ.
- Cruz JC, Rode EC , Gomez LS, et al. Celiac disease as- sociated antibodies in persons with latent autoimmune diabetes of adult and type 2 diabetes. Autoimmunity 2007 Mar; 40(2): 103-7
- Catassi C, Fabiani E, R?tsch IM, Coppa GV, Giorgi PL, et al. The coeliac iceberg in Italy. A multicentre antigli- adin antibodies screening for coeliac disease in school- age subjects. Acta Paediatr Suppl. 1996 May; 412: 29-35
- De Vitis I, Ghirlanda G, Gasbarrini G. Prevalence of coeliac disease in type I diabetes: a multicentre study. Acta Paediatr Suppl. 1996;412:56-57
- Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac dis- ease. Nat Med. 1997; 3: 797-801
- Logan RF, Rifkind EA, Turner ID, Ferguson A. Mortality in celiac disease. Gastroenterology. 1989; 97: 265-271
- Lerner A, Lebenthal E. The controversy of the use of anti-gluten antibody (AGA) as a diagnostic tool in celiac disease. J Pediatr Gastroenterol Nutr. 1991; 12: 407-409
- Ascher H, Hahn-Zoric M, Hansson L?, Kilander AF, Nilsson L?, Tlaskalova′ H. Value of serologic markers for clinical diagnosis and population studies of coeliac disease. Scand J Gastroenterol. 1996; 31: 61-67
- Bürgin-Wolff A, Gaze H, Hadziselimovic F, et al. An- tigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child. 1991; 66: 941-947
- Farrell RJ, Kelly CP. Current concepts: celiac sprue . N Engl J Med 2002; 346:180-188.
- Lorini R, Scaramuzza A, Vitali L, et el. Clinical aspects of coeliac disease in children with insulin-dependent dia- betes mellitus. J Pediatr Endocrinol Metab. 1996; 9: 101-111
- Markku M, Pekka C. Celiac disease. Lancet 1997; 349: 1755-9.
- Corazza GR, Biagi F, Andreani ML, et al. Screening test for celiac disease. Lancet 1997; 349: 325-6.
- Corrao G, Corazza GR, Andreani ML, et al. Serological screening of celiac disease: Choosing the optimal pro- cedure according to various prevalence values. Gut 1994; 35: 771-5.